May 16, 2020
Thomas Kleen, PhD, Exec. VP Immune Monitoring, Epiontis, spoke at the 6th Cancer Therapeutics & Partnering Summit by GTCbio.
Precision for Medicine is part of the Precision Medicine Group, an integrated team of experts that extends Precision for Medicine’s therapeutic development capabilities beyond approval and into launch strategies, marketing communication, and payer insights. As one company, the Precision Medicine Group helps pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.
